More people affected by memory diseases in aging society

As the population ages, more people are affected by memory diseases like Alzheimer's. However, research in the field is progressing slowly, and only about half of those affected receive the available treatment.

In an opinion piece in Dagens Nyheter, Lisa Magnusson questions how pleasant the final years of life will truly be for many elderly people. She notes that as lifespans increase, more individuals are affected by memory diseases. Despite this, research in the area is advancing slowly.

The article states that only about half of those suffering from Alzheimer's receive the treatment that is actually available. This raises concerns about how society addresses the rising prevalence of these conditions. Magnusson emphasizes the need for better support and progress in healthcare to ensure a dignified old age.

The piece was published on January 10, 2026, and is part of DN's editorial page, focusing on debate and reflection on societal issues.

Articoli correlati

Diverse young adults reviewing charts on rising cognitive disabilities in a community setting, illustrating a Neurology study on surges among under-40s due to social and economic factors.
Immagine generata dall'IA

Self-reported cognitive disabilities surge among young U.S. adults

Riportato dall'IA Immagine generata dall'IA Verificato

A peer-reviewed Neurology study finds a sharp rise in self-reported cognitive difficulties among U.S. adults from 2013 to 2023, with rates nearly doubling in people under 40 and the steepest increases among lower-income and less-educated groups. Authors point to social and economic factors and call for further study.

Una forma di demenza recentemente riconosciuta, nota come LATE, sta ridefinendo la comprensione del declino cognitivo negli anziani, con diagnosi in aumento e linee guida per i medici pubblicate quest'anno. Si stima che colpisca circa un terzo delle persone di 85 anni o più e il 10% di quelle di 65 anni o più, spesso confusa con l'Alzheimer. Gli esperti sottolineano la necessità di un più ampio spettro di trattamenti per questa condizione.

Riportato dall'IA

Alzheimer's trials are shifting to a multi-target approach inspired by cancer research, even after failures with Novo Nordisk's semaglutide. Only two drugs, Eli Lilly's Kisunla and Eisai and Biogen's Leqembi, are widely approved to slow progression. This evolution treats the brain-wasting disease as a complex system, seeking new ways to halt it amid its global impact.

A 20-year randomized controlled trial has shown that cognitive speed training, combined with booster sessions, reduces the risk of dementia diagnosis by 25 percent among older adults. The study, involving over 2,800 participants aged 65 and older, focused on a computer-based task requiring quick recall of visual details. While results are promising, experts urge caution due to the study's multiple outcome measures.

Riportato dall'IA

High meat intake may reduce dementia risk for older people with genetic predisposition to Alzheimer's, per a Karolinska Institutet study. The study tracked over 2,100 individuals aged 60 and older for up to 15 years. Findings apply to carriers of specific apoe gene variants.

Gli scienziati europei hanno sviluppato un metodo preliminare per identificare l'Alzheimer utilizzando una goccia di sangue essiccato da un dito, raggiungendo l'86% di accuratezza nel rilevare la patologia amiloide. Lo studio, validato su 337 pazienti di diversi paesi, è pubblicato su Nature Medicine e mira a semplificare la diagnosi precoce di questa malattia che colpisce oltre 50 milioni di persone in tutto il mondo.

Riportato dall'IA

Half a million people in Sweden aged 16 and older will receive a letter in the coming days with questions from the Public Health Agency about their health and lifestyle habits. The national survey 'Health on Equal Terms' covers areas such as safety, stress, diet, and alcohol. The aim is to map differences in well-being between various groups.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta